Home > Income Statement > SUDARSHAN PHARMA INDUSTRIES

SUDARSHAN PHARMA INDUSTRIES
Revenue

    Back to Income Statement
SUDARSHAN PHARMA INDUSTRIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SUDARSHAN PHARMA INDUSTRIES
Please provide your vote to see the results

SUDARSHAN PHARMA INDUSTRIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹505 Cr₹464 Cr₹461 Cr₹357 Cr₹193 Cr

What is the latest Revenue of SUDARSHAN PHARMA INDUSTRIES ?

The latest Revenue ratio of SUDARSHAN PHARMA INDUSTRIES is ₹505 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹505 Cr
Mar2025₹464 Cr
Mar2024₹461 Cr
Mar2023₹357 Cr
Mar2022₹193 Cr

How is Revenue of SUDARSHAN PHARMA INDUSTRIES Trending?

Years Revenue % Change
Mar2026 ₹505 Cr
8.95
Mar2025 ₹464 Cr
0.48
Mar2024 ₹461 Cr
29.19
Mar2023 ₹357 Cr
84.69
Mar2022 ₹193 Cr -

Compare Revenue of peers of SUDARSHAN PHARMA INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUDARSHAN PHARMA INDUSTRIES ₹912.1 Cr 12% -4.1% 53.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUDARSHAN PHARMA INDUSTRIES

12%

-4.1%

53.6%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses